411 related articles for article (PubMed ID: 19619685)
41. [The Tropical Diseases Research program in the International Year of Peace].
Piédrola Gil G; Piédrola Angulo G
An R Acad Nac Med (Madr); 1986; 103(3):383-410. PubMed ID: 3826567
[No Abstract] [Full Text] [Related]
42. African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan).
Dimomfu BL; Lubeji DK; Noma M; Sékétéli A; Boussinesq M;
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):674-9. PubMed ID: 17433391
[TBL] [Abstract][Full Text] [Related]
43. Onchocerciasis: a review of clinical, pathologic and chemotherapeutic aspects, and vector control program.
Gibson DW; Duke BO; Connor DH
Prog Clin Parasitol; 1989; 1():57-103. PubMed ID: 2491695
[No Abstract] [Full Text] [Related]
44. From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
Colebunders R; Siewe Fodjo JN; Hopkins A; Hotterbeekx A; Lakwo TL; Kalinga A; Logora MY; Basáñez MG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007407. PubMed ID: 31318857
[No Abstract] [Full Text] [Related]
45. Control of onchocerciasis today: status and challenges.
Richards FO; Boatin B; Sauerbrey M; Sékétéli A
Trends Parasitol; 2001 Dec; 17(12):558-63. PubMed ID: 11756018
[No Abstract] [Full Text] [Related]
46. Progress toward elimination of onchocerciasis in the Americas.
Sauerbrey M; Rakers LJ; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
[TBL] [Abstract][Full Text] [Related]
47. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control.
World Health Organ Tech Rep Ser; 1995; 852():1-104. PubMed ID: 7541171
[No Abstract] [Full Text] [Related]
48. Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis.
Abanobi OC; Chukwuocha UM; Onwuiiliri CO; Opara KC
East Afr J Public Health; 2011 Mar; 8(1):33-7. PubMed ID: 22066280
[TBL] [Abstract][Full Text] [Related]
49. River blindness: a gamble pays off.
Walsh J
Science; 1986 May; 232(4753):922-5. PubMed ID: 3754652
[No Abstract] [Full Text] [Related]
50. Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.
Plaisier AP; Alley ES; van Oortmarssen GJ; Boatin BA; Habbema JD
Bull World Health Organ; 1997; 75(3):237-45. PubMed ID: 9277011
[TBL] [Abstract][Full Text] [Related]
51. Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
Koala L; Nikiema A; Post RJ; Paré AB; Kafando CM; Drabo F; Traoré S
Acta Trop; 2017 Feb; 166():96-105. PubMed ID: 27845063
[TBL] [Abstract][Full Text] [Related]
52. The First Confirmed Elimination of an Onchocerciasis Focus in Africa: Abu Hamed, Sudan.
Zarroug IM; Hashim K; ElMubark WA; Shumo ZA; Salih KA; ElNojomi NA; Awad HA; Aziz N; Katabarwa M; Hassan HK; Unnasch TR; Mackenzie CD; Richards F; Higazi TB
Am J Trop Med Hyg; 2016 Nov; 95(5):1037-1040. PubMed ID: 27352878
[TBL] [Abstract][Full Text] [Related]
53. The distribution, bionomics and control of onchocerciasis vectors (Diptera: Simuliidae) in Eastern Africa and the Yemen.
Raybould JN; White GB
Tropenmed Parasitol; 1979 Dec; 30(4):505-47. PubMed ID: 538821
[No Abstract] [Full Text] [Related]
54. Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
Thylefors B; Alleman MM; Twum-Danso NA
Trop Med Int Health; 2008 May; 13(5):689-96. PubMed ID: 18419585
[TBL] [Abstract][Full Text] [Related]
55. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
[TBL] [Abstract][Full Text] [Related]
56. The elimination of the vector Simulium neavei from the Itwara onchocerciasis focus in Uganda by ground larviciding.
Garms R; Lakwo TL; Ndyomugyenyi R; Kipp W; Rubaale T; Tukesiga E; Katamanywa J; Post RJ; Amazigo UV
Acta Trop; 2009 Sep; 111(3):203-10. PubMed ID: 19446785
[TBL] [Abstract][Full Text] [Related]
57. Elimination of
Katabarwa MN; Habomugisha P; Khainza A; Oguttu D; Byamukama E; Katamanywa J; Isingooma T; Bwenume F; Nahabwe C; Ngabirano M; Akampurira P; Bernard L; Unnasch TR; Richards F
Am J Trop Med Hyg; 2020 Sep; 103(3):1135-1142. PubMed ID: 32588807
[TBL] [Abstract][Full Text] [Related]
58. Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control.
Brieger WR; Okeibunor JC; Abiose AO; Ndyomugyenyi R; Kisoka W; Wanji S; Elhassan E; Amazigo UV
Trop Med Int Health; 2007 Feb; 12(2):260-8. PubMed ID: 17300634
[TBL] [Abstract][Full Text] [Related]
59. Status of forest onchocerciasis in the Lower Cross River basin, Nigeria: entomologic profile after five years of ivermectin intervention.
Opara KN; Fagbemi OB; Ekwe A; Okenu DM
Am J Trop Med Hyg; 2005 Aug; 73(2):371-6. PubMed ID: 16103607
[TBL] [Abstract][Full Text] [Related]
60. Entomological evaluation by pool screen polymerase chain reaction of Onchocerca volvulus transmission in Ecuador following mass Mectizan distribution.
Guevara AG; Vieira JC; Lilley BG; López A; Vieira N; Rumbea J; Collins R; Katholi CR; Unnasch TR
Am J Trop Med Hyg; 2003 Feb; 68(2):222-7. PubMed ID: 12641415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
